Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD
Center for International Blood and Marrow Transplant Research
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Phoenix
Phoenix, Arizona, United States
- University of California, San Diego Medical Center
La Jolla, California, United States
- University of Florida College of Medicine
Gainesville, Florida, United States
- Florida Hospital Cancer Institute
Orlando, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Blood and Marrow Transplant Program at Northside Hospital
Atlanta, Georgia, United States
- Emory University
Atlanta, Georgia, United States
- University of Kansas
Kansas City, Kansas, United States
- University of Kentucky
Lexington, Kentucky, United States
- Dfci, Brigham & Women'S Hospital
Boston, Massachusetts, United States
- Karmanos Cancer Institute
Detroit, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Washington University/barnes Jewish Hospital
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Mount Sinai Medical Center
New York, New York, United States
- University of Rochester Medical Center
Rochester, New York, United States
- University of North Carolina Hospital at Chapel Hill
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Jewish Hospital Bmt Program
Cincinnati, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University Hospitals of Cleveland/case Western
Cleveland, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Baylor University Medical Center
Dallas, Texas, United States
- Texas Transplant Institute
San Antonio, Texas, United States
- Utah Bmt/university of Utah Medical School
Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- West Virginia University Hospital
Morgantown, West Virginia, United States
- University of Wisconsin Hospital & Clinics
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2011
- Primary completion
- 16 Jan 2017
- Completion
- 16 Oct 2017
- Last update posted
- 4 Jan 2023
- Registered enrollment
- 272
- Registry id
- NCT01339910
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.